# A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD

> **NCT00419744** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1200 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Budesonide/formoterol (SYMBICORT) pMDI
- **DRUG:** Formoterol Turbuhaler

## Key facts

- **NCT ID:** NCT00419744
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2010-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00419744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00419744, "A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00419744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*